[{"address1": "5 Science Park", "address2": "395 Winchester Avenue", "city": "New Haven", "state": "CT", "zip": "06511", "country": "United States", "phone": "203 535 1456", "website": "https://www.arvinas.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Arvinas, Inc., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. The company engineers proteolysis targeting chimeras (PROTAC) targeted protein degraders that are designed to harness the body's own natural protein disposal system to degrade and remove disease-causing proteins. Its product pipeline includes Bavdegalutamide and ARV-766, investigational orally bioavailable PROTAC protein degraders for the treatment of men with metastatic castration-resistant prostate cancer, which are in Phase 3 clinical trials; and ARV-471, an orally bioavailable estrogen receptor degrading PROTAC targeted protein degrader for the treatment of patients with locally advanced or metastatic estrogen receptor+/human epidermal growth factor receptor 2-breast cancer, which is Phase 3 clinical trial. The company's products also consists ARV 393, orally bioavailable PROTAC designed to degrade BCL6, a transcriptional repressor and a key regulator of normal B-cell maturation and differentiation processes which is in Phase 1 first-in-human clinical trial; ARV 102 for the treatment of neurodegenerative diseases, which is in Phase 1 clinical trial; and KRAS G12D program is in preclinical development for pancreatic and colorectal cancers. Arvinas, Inc. has collaborations with Pfizer Inc., Genentech, Inc., F. Hoffman-La Roche Ltd., Carrick Therapeutics Limited, and Bayer AG. The company was founded in 2013 and is based in New Haven, Connecticut.", "fullTimeEmployees": 430, "companyOfficers": [{"maxAge": 1, "name": "Mr. Andrew R. Saik", "age": 56, "title": "CFO & Treasurer", "yearBorn": 1969, "fiscalYear": 2024, "totalPay": 657193, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Angela M. Cacace Ph.D.", "age": 57, "title": "Chief Scientific Officer", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 696153, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 3, "boardRisk": 9, "compensationRisk": 10, "shareHolderRightsRisk": 8, "overallRisk": 9, "governanceEpochDate": 1769904000, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 11.835, "open": 12.2, "dayLow": 11.56, "dayHigh": 12.5, "regularMarketPreviousClose": 11.835, "regularMarketOpen": 12.2, "regularMarketDayLow": 11.56, "regularMarketDayHigh": 12.5, "payoutRatio": 0.0, "beta": 1.882, "forwardPE": -3.962895, "volume": 785522, "regularMarketVolume": 785522, "averageVolume": 1259835, "averageVolume10days": 769320, "averageDailyVolume10Day": 769320, "bid": 8.77, "ask": 11.68, "bidSize": 2, "askSize": 2, "marketCap": 855314944, "fiftyTwoWeekLow": 5.9, "fiftyTwoWeekHigh": 20.38, "allTimeHigh": 108.47, "allTimeLow": 5.9, "priceToSalesTrailing12Months": 2.7387607, "fiftyDayAverage": 12.5044, "twoHundredDayAverage": 9.313, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -30086974, "profitMargins": -0.18732001, "floatShares": 56092214, "sharesOutstanding": 64224294, "sharesShort": 4262275, "sharesShortPriorMonth": 4859281, "sharesShortPreviousMonthDate": 1767139200, "dateShortInterest": 1769731200, "sharesPercentSharesOut": 0.0664, "heldPercentInsiders": 0.07881, "heldPercentInstitutions": 0.88989997, "shortRatio": 5.63, "shortPercentOfFloat": 0.067600004, "impliedSharesOutstanding": 73417595, "bookValue": 7.972, "priceToBook": 1.4613647, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -58500000, "trailingEps": -0.81, "forwardEps": -2.93977, "enterpriseToRevenue": -0.096, "enterpriseToEbitda": 0.307, "52WeekChange": -0.36514747, "SandP52WeekChange": 0.11471915, "quoteType": "EQUITY", "currentPrice": 11.65, "targetHighPrice": 18.0, "targetLowPrice": 6.0, "targetMeanPrice": 13.5, "targetMedianPrice": 14.5, "recommendationMean": 2.15789, "recommendationKey": "buy", "numberOfAnalystOpinions": 16, "totalCash": 787600000, "totalCashPerShare": 12.263, "ebitda": -98000000, "totalDebt": 9300000, "quickRatio": 5.62, "currentRatio": 5.703, "totalRevenue": 312300000, "debtToEquity": 1.648, "revenuePerShare": 4.299, "returnOnAssets": -0.06302, "returnOnEquity": -0.1017, "grossProfits": 312300000, "freeCashflow": -134575008, "operatingCashflow": -327500000, "revenueGrowth": -0.591, "grossMargins": 1.0, "ebitdaMargins": -0.31379998, "operatingMargins": -1.05012, "financialCurrency": "USD", "symbol": "ARVN", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "postMarketChangePercent": 0.17167775, "postMarketPrice": 11.67, "postMarketChange": 0.020000458, "regularMarketChange": -0.185, "regularMarketDayRange": "11.56 - 12.5", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 1259835, "fiftyTwoWeekLowChange": 5.7499995, "fiftyTwoWeekLowChangePercent": 0.9745762, "fiftyTwoWeekRange": "5.9 - 20.38", "fiftyTwoWeekHighChange": -8.73, "fiftyTwoWeekHighChangePercent": -0.42836115, "fiftyTwoWeekChangePercent": -36.514748, "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1771026593, "regularMarketTime": 1771016402, "exchange": "NMS", "messageBoardId": "finmb_243040896", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -1.56316, "regularMarketPrice": 11.65, "earningsTimestampStart": 1771335000, "earningsTimestampEnd": 1771335000, "earningsCallTimestampStart": 1762347600, "earningsCallTimestampEnd": 1762347600, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.81, "epsForward": -2.93977, "epsCurrentYear": -0.72329, "priceEpsCurrentYear": -16.106955, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1538055000000, "fiftyDayAverageChange": -0.85440063, "fiftyDayAverageChangePercent": -0.068328, "twoHundredDayAverageChange": 2.337, "twoHundredDayAverageChangePercent": 0.25093955, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.2 - Buy", "cryptoTradeable": false, "shortName": "Arvinas, Inc.", "longName": "Arvinas, Inc.", "displayName": "Arvinas", "trailingPegRatio": null, "__fetch_time": "2026-02-14"}]